| AE | Adverse Event |
| AChR | Acetylcholine Receptor |
| AChR-Ab | Anti-Acetylcholine Receptor Antibody |
| AZA | Azathioprine |
| CBA | Cell-Based Assay |
| gMG | Generalized Myasthenia Gravis |
| IS | Immunosuppressant(s) |
| IV | Intravenously |
| IVIg | Intravenous Immunoglobulin |
| MAC | Membrane Attack Complex |
| MCID | Minimal Clinically Important Difference |
| MG | Myasthenia Gravis |
| MG-ADL | Myasthenia Gravis Activities of Daily Living |
| MGFA | Myasthenia Gravis Foundation of America |
| MMF | Mycophenolate Mofetil |
| MMS | Minimal Manifestations Status |
| NMJ | Neuromuscular Junction |
| PLEX | Plasma Exchange |
| QMG | Quantitative Myasthenia Gravis |
| RIA | Radio-Immunoassay |
| SD | Standard Deviation |